Gilbert Bigras

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

Manfred Dietel, Rubén Salanova, Patrick Micke et al. · Lung Cancer · 2019 · 160 citations

Medicine, Cancer Biology, Oncology +13

Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer

Jean‐Claude Cutz, Kenneth J. Craddock, Emina Torlakovic et al. · Journal of Thoracic Oncology · 2014 · 79 citations

Medicine, Oncology, Pathology +13

The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women

Gilbert Bigras, Floriane de Marval · British Journal of Cancer · 2005 · 74 citations · Full text

Medicine, Gynecology, Pathology +15

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)

Carol C. Cheung, Penny J. Barnes, Gilbert Bigras et al. · Applied immunohistochemistry & molecular morphology · 2019 · 55 citations · Full text

Medicine, Oncology, Pathology +17

The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer

Satbir Thakur, Haocheng Li, Angela Chan et al. · PLoS ONE · 2018 · 53 citations · Full text

Medicine, Cancer Biology, Oncology +16